Tripartite Deal Signed to Produced Sinopharm Vaccine in Bangladesh

A tripartite agreement has been signed between Sinopharm, Ministry of Health and Family Welfare and Incepta Pharmaceuticals for the production of Chinese Sinopharm vaccine in the country. 

The agreement was signed at the auditorium of Bangladesh College of Physicians and Surgeons (BCPS) in the capital's Mohakhali on Monday (August 16) afternoon.

The agreement was signed by Health Minister Zahid Malek, Chinese Ambassador Li Jiming and Abdul Muktadir, Chairman of Incepta Vaccine Limited and Incepta Pharmaceuticals Limited.

Health Minister Zahid Malek was present as the chief guest on the occasion. Foreign Minister AK Abdul Mamen was present as the guest of honor. Foreign Secretary Masood Bin Mamen, Chinese Ambassador Li Jiming, Director General of the Department of Drug Administration Major General Md Mahbubur Rahman, Chairman of Incepta Vaccine Limited and Chairman of Incepta Pharmaceuticals Limited Abdul Muktadir were present as special guests on the occasion.  

Prof. Dr Abul Bashar Mohammad Khurshid Alam, Director General, Department of Health, gave a welcome address at the function presided over by Lokman Hassan Miah, Senior Secretary, Department of Health, Ministry of Health.

The speakers hoped that the agreement would enable Incepta to produce vaccines faster.

Speakers at the event also said that a new direction was unveiled in the production of covid vaccine in Bangladesh in August, the month of mourning.